-
Mashup Score: 0
NCT03917914; CTRI/2020/08/027322.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Quality of life not significantly improved in AF, symptomatic HF with digoxin, bisoprolol - 3 year(s) ago
At 6 months, quality of life in patients with permanent atrial fibrillation and symptomatic HF treated with digoxin was not significantly different vs. those treated with bisoprolol, researchers reported.According to research published in JAMA, although symptom control for AF and symptomatic HF was better among patients prescribed digoxin, the between-group difference for the primary endpoint of
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ICYMI: “These findings support basing decisions about treatment on other endpoints,” #AFib #digoxin #bisoprolol #Cardiotwitter https://t.co/2IvE52WNg4
-
-
Mashup Score: 0Quality of life not significantly improved in AF, symptomatic HF with digoxin, bisoprolol - 3 year(s) ago
At 6 months, quality of life in patients with permanent atrial fibrillation and symptomatic HF treated with digoxin was not significantly different vs. those treated with bisoprolol, researchers reported.According to research published in JAMA, although symptom control for AF and symptomatic HF was better among patients prescribed digoxin, the between-group difference for the primary endpoint of
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ICYMI: “These findings support basing decisions about treatment on other endpoints,” #AFib #digoxin #bisoprolol #Cardiotwitter https://t.co/2IvE52WNg4
-
-
Mashup Score: 5Quality of life not significantly improved in AF, symptomatic HF with digoxin, bisoprolol - 3 year(s) ago
At 6 months, quality of life in patients with permanent atrial fibrillation and symptomatic HF treated with digoxin was not significantly different vs. those treated with bisoprolol, researchers reported.According to research published in JAMA, although symptom control for AF and symptomatic HF was better among patients prescribed digoxin, the between-group difference for the primary endpoint of
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
At 6 months, quality of life in patients with permanent #AFib and symptomatic HF treated with #digoxin was not significantly different vs. those treated with #bisoprolol #Cardiotwitter https://t.co/2IvE52WNg4
-
Preventing adverse #cardiac #events ( #PACE) in #chronic #obstructive #pulmonary #disease ( #COPD): study protocol for a double-blind, placebo controlled, randomised controlled trial of #bisoprolol in #COPD https://t.co/8jiJt1VfWH https://t.co/UhscVVEtj3